Clinical Trial Update: Magnetic Marker Monitoring of Furosemide-containing Gastroretentive Formulation in Healthy Male Subjects (Fasting and Fed Conditions) [Phase 1]

View source ↗

Summary

Phase 1 trial update indicating completion of a study that uses magnetic marker monitoring for a furosemide-containing gastroretentive formulation in healthy ma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Edema

Drugs mentioned

• FUROSEMIDE (Furosemide)

Snippet

Sponsor: LTS Lohmann Therapie-Systeme AG | Conditions: Gastroretentive Drug Formulation of Furosemide, Oedema | Phase 1 | Status: COMPLETED